Effect of efonidipine hydrochloride (NZ-105), a dihydropyridine derivative with calcium antagonistic action, on myocardial oxygen tension in anesthetized dogs

Folia Pharmacologica Japonica

Volumn 108, Issue 5, 1996, Pages 267-274

  Fujikura, Naoki ^a   Yokoyama, Tatsuro ^a   Masuda, Yukinori ^a   Shikada, Ken Ichi ^a   Tanaka, Sakuya ^a  

^a NISSAN CHEMICAL INDUSTRIES LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDROPYRIDINE DERIVATIVE; EFONIDIPINE; NIFEDIPINE; NISOLDIPINE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CALCIUM ANTAGONISM; CORONARY ARTERY BLOOD FLOW; DOG; DOSE RESPONSE; INTRAVENOUS DRUG ADMINISTRATION; MEAN ARTERIAL PRESSURE; NONHUMAN; OXYGEN SUPPLY; OXYGEN TENSION; RAT;

EID: 0029846611     PISSN: 00155691     EISSN: None     Source Type: Journal    
DOI: 10.1254/fpj.108.267     Document Type: Article

References (22)

1. Gross GJ, Warltier DC and Hardman HF: Comparative effects of FR 34235, a new slow channel calcium blocker, and nifedipine on hemodynamics and myocardial oxygen consumption in the anesthetized dog. Gen Pharmacol 14, 677-680 (1983)
2. Kazda S, Garthoff B, Meyer H, Schloßmann K, Stoepel K, Towart R, Vater W and Wehinger E: Pharmacology of a new calcium antagonistic compound, isobutyl methyl 1,4-dihydro-2,6- dimethyl-4-(2-nitrophenyl)-3, 5-pyridinedicarboxylate (nisoldipine, BAY k 5552). Arzneimittelforschung 30, 2144-2162 (1980)
3. Nitrendipine 92, 397-410 (1988)
4. Hashimoto H, Asano M, Takiguchi Y, Katoh H and Nakashima M: Effects of nicardipine, a dihydropyridine calcium antagonist, on regional myocardial blood flow, myocardial oxygen tension, and electrical abnormalities during acute coronary artery occlusion in dogs. J Cardiovasc Pharmacol 7, 613-621 (1985)
5. Gross GJ and Warltier DC: Selective improvement in subendocardial perfusion distal to a flow-limiting coronary artery stenosis: effects of the new calcium channel blocking agent, FR34235, nifedipine and diltiazem. J Pharmacol Exp Ther 228, 531-536 (1984)
6. Alps BJ, Calder C, Wilson A and Scott-Park FM: The beneficial effect of nicardipine on the healing of myocardial infarcts in dogs. Arzneimittelforschung 33, 1638-1646 (1983)
7. Masuda Y and Tanaka S: Efonidipine hydrochloride: A new calcium antagonist. Cardiovasc Drug Rev 12, 123-135 (1994)
8. Masuda Y, Takeguchi M, Arakawa C, Sakai T, Hibi M, Tanaka S, Shigenobu K and Kasuya Y: Antihypertensive and diuretic effects of NZ-105, a novel dihydropyridine derivative. Arch Int Pharmacodyn Ther 304, 247-264 (1990)
9. (±)-2-[benzyl (phenyl)amino]ethyl 1, 4- dihydro-2,6-dimethyl-5-(5,5-dimethyl-2-oxo-1, 3, 2-dioxaphosphorinan-2-yl)-4-(3-nitrophenyl)-3-pyridinecarboxylate hydrochloride ethanol (NZ-105) 42, 55-60 (1991)
10. 11) Dihydropyridine (±)-2-[benzyl(phenyl)amino]ethyl 1,4-dihydro-2, 6- dimethyl-5-(5,5-dimethyl-2-oxo-1,3,2-dioxaphosphorinan-2-yl)-4-(3-nitrophenyl)- 3-pyridinecarboxylate hydrochloride ethanol (NZ-105) 42, 43-54 (1991)
11. Pedersen OL and Mikkelsen E: Acute and chronic effects of nifedipine in arterial hypertension. Eur J Clin Pharmacol 14, 375-381 (1978)
12. Olivari MT, Bartorelli C, Polese A, Fiorentini C, Moruzzi P and Guazzi MD: Treatment of hypertension with nifedipine, a calcium antagonistic agent. Circulation 59, 1056-1062 (1979)
13. Warltier DC, Meils CM, Gross GJ and Brooks HL: Blood flow in normal and acutely ischemic myocardium after verapamil, diltiazem and nisoldipine (Bay k 5552), a new dihydropyridine calcium antagonist. J Pharmacol Exp Ther 218, 296-302 (1981)
14. Rousseau G, Provost P, Tran D, Caillé G and Latour JG: Clentiazem given at reperfusion improves subendocardial reflow and reduces myocardial infarct size in the dog. J Pharmacol Exp Ther 268, 1252-1260 (1994)
15. Weiss HR and Winbury MM: Intracoronary nitroglycerin, pentaerythritol trinitrate and dipyridamole on intramyocardial oxygen tension. Microvasc Res 4, 273-284 (1972)
16. Winbury MM, Howe BB and Weiss HR: Effect of nitroglycerin and dipyridamole on epicardial and endocardial oxygen tension - further evidence for redistribution of myocardial blood flow. J Pharmacol Exp Ther 176, 184-199 (1971)
17. Jolly SR, Hardman HF and Gross GJ: Comparison of two dihydropyridine calcium antagonists on coronary collateral blood flow in acute myocardial ischemia. J Pharmacol Exp Ther 217, 20-25 (1981)
18. Warltier DC, Meils CM, Gross GJ and Brooks HL: Blood flow in nomal and acutely ischemic myocardium after verapamil, diltiazem and nisoldipine (Bay k 5552), a new dihydropyridine calcium antagonist. J Pharmacol Exp Ther 218, 296-302 (1981)
19. Warltier DC, Hardman HF, Brooks HL and Gross GJ: Transmural gradient of coronary blood flow following dihydropyridine calcium antagonists and other vasodilator drugs. Basic Res Cardiol 78, 644-653 (1983)
20. Nomura H, Nagata K, Futamura Y, Mochizuki K, Kama Y, Sotobata I and Yasui S: Effects of niludipine on regional myocardial blood flow and regional myocardial function in the dog with partial occlusion of the coronary artery. Arzneimittelforschung 30, 1258-1263 (1980)